Chang JW - Search Results

1

Brn3a/Pou4f1 Functions as a Tumor Suppressor by Targeting c-MET/STAT3 Signaling in Thyroid Cancer.

Jung SN, Kang YE, Lee GH, Liu L, Oh C, Jin YL, Lim MA, Lee K, Oh T, Won HR, Chang JW, Koo BS. Jung SN, et al. Among authors: chang jw. J Clin Endocrinol Metab. 2020 Sep 1;105(9):dgaa316. doi: 10.1210/clinem/dgaa316. J Clin Endocrinol Metab. 2020. PMID: 32474599

2

Transient and permanent hypocalcemia after total thyroidectomy: Early predictive factors and long-term follow-up results.

Seo ST, Chang JW, Jin J, Lim YC, Rha KS, Koo BS. Seo ST, et al. Among authors: chang jw. Surgery. 2015 Dec;158(6):1492-9. doi: 10.1016/j.surg.2015.04.041. Epub 2015 Jul 2. Surgery. 2015. PMID: 26144879

3

c-Met-mediated reactivation of PI3K/AKT signaling contributes to insensitivity of BRAF(V600E) mutant thyroid cancer to BRAF inhibition.

Byeon HK, Na HJ, Yang YJ, Kwon HJ, Chang JW, Ban MJ, Kim WS, Shin DY, Lee EJ, Koh YW, Yoon JH, Choi EC. Byeon HK, et al. Among authors: chang jw. Mol Carcinog. 2016 Nov;55(11):1678-1687. doi: 10.1002/mc.22418. Epub 2015 Oct 12. Mol Carcinog. 2016. PMID: 26456083

4

EZH2 is associated with poor prognosis in head-and-neck squamous cell carcinoma via regulating the epithelial-to-mesenchymal transition and chemosensitivity.

Chang JW, Gwak SY, Shim GA, Liu L, Lim YC, Kim JM, Jung MG, Koo BS. Chang JW, et al. Oral Oncol. 2016 Jan;52:66-74. doi: 10.1016/j.oraloncology.2015.11.002. Epub 2015 Nov 18. Oral Oncol. 2016. PMID: 26604082

5

Carboxyl-Terminal Modulator Protein Positively Acts as an Oncogenic Driver in Head and Neck Squamous Cell Carcinoma via Regulating Akt phosphorylation.

Chang JW, Jung SN, Kim JH, Shim GA, Park HS, Liu L, Kim JM, Park J, Koo BS. Chang JW, et al. Sci Rep. 2016 Jun 22;6:28503. doi: 10.1038/srep28503. Sci Rep. 2016. PMID: 27328758 Free PMC article.

6

Lateral lymph node recurrence after total thyroidectomy and central neck dissection in patients with papillary thyroid cancer without clinical evidence of lateral neck metastasis.

Lim YC, Liu L, Chang JW, Koo BS. Lim YC, et al. Among authors: chang jw. Oral Oncol. 2016 Nov;62:109-113. doi: 10.1016/j.oraloncology.2016.10.010. Epub 2016 Oct 22. Oral Oncol. 2016. PMID: 27865362

7

Clinical implications of the extent of BRAF^V600E alleles in patients with papillary thyroid carcinoma.

Liu L, Chang JW, Jung SN, Park HS, Oh T, Lim YC, Koo BS. Liu L, et al. Among authors: chang jw. Oral Oncol. 2016 Nov;62:72-77. doi: 10.1016/j.oraloncology.2016.10.005. Epub 2016 Oct 19. Oral Oncol. 2016. PMID: 27865374

8

Clinical implications of microscopic extrathyroidal extension in patients with papillary thyroid carcinoma.

Park JS, Chang JW, Liu L, Jung SN, Koo BS. Park JS, et al. Among authors: chang jw. Oral Oncol. 2017 Sep;72:183-187. doi: 10.1016/j.oraloncology.2017.02.008. Epub 2017 Feb 20. Oral Oncol. 2017. PMID: 28222967

9

High Expression of Angiopoietin-1 is Associated with Lymph Node Metastasis and Invasiveness of Papillary Thyroid Carcinoma.

Kang YE, Kim KS, Park SJ, Jung SN, Chang JW, Yi S, Jung MG, Kim JM, Koo BS. Kang YE, et al. Among authors: chang jw. World J Surg. 2017 Dec;41(12):3128-3138. doi: 10.1007/s00268-017-4111-7. World J Surg. 2017. PMID: 28717903

10

Relationship Between ¹⁸F-fluorodeoxyglucose Accumulation and the BRAF ^V600E Mutation in Papillary Thyroid Cancer.

Chang JW, Park KW, Heo JH, Jung SN, Liu L, Kim SM, Kwon IS, Koo BS. Chang JW, et al. World J Surg. 2018 Jan;42(1):114-122. doi: 10.1007/s00268-017-4136-y. World J Surg. 2018. PMID: 28808756

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,161 results

Search Page

Filters